{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:20:32Z","timestamp":1770438032961,"version":"3.49.0"},"reference-count":20,"publisher":"SMC Media","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>.<\/jats:p>","DOI":"10.12890\/2026_006063","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:06:08Z","timestamp":1768485968000},"source":"Crossref","is-referenced-by-count":0,"title":["Clarifying the diagnosis of Epstein-Barr virus related myositis in a genetically confirmed mitochondrial diabetes patient"],"prefix":"10.12890","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3562-8810","authenticated-orcid":false,"given":"Michalis","family":"Picolos","sequence":"first","affiliation":[{"name":"Alithias Endocrinology Center, Nicosia, Cyprus; European University, Nicosia, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8964-8345","authenticated-orcid":false,"given":"Anna","family":"Kyriakidou","sequence":"first","affiliation":[{"name":"Royal Free Foundation Trust, Barnet Hospital, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6157-2761","authenticated-orcid":false,"given":"Anastasia","family":"Papapostolou","sequence":"first","affiliation":[{"name":"Alithias Endocrinology Center, Nicosia, Cyprus; European University, Nicosia, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8143-7145","authenticated-orcid":false,"given":"Georgios S.","family":"Papaetis","sequence":"first","affiliation":[{"name":"K.M.P THERAPIS Paphos Medical Center, Internal Medicine and Diabetes Clinic, Paphos, Cyprus; CDA College, Paphos, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10397","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"10.12890\/2026_006063_ref1","doi-asserted-by":"crossref","unstructured":"Finsterer J. Only diagnose EBV-related myositis in a patient with mitochondrial myopathy after detecting the virus in the muscle. Int J Adv Multidiscip Res Stud 2025;5:934\u2013935- doi: 10.62225\/2583049X.2025.5.5.5027","DOI":"10.62225\/2583049X.2025.5.5.5027"},{"key":"10.12890\/2026_006063_ref2","doi-asserted-by":"crossref","unstructured":"Kyriakidou A, Papapostolou A, Picolos MK. Epstein-Barr Virus Induced Myositis in a Patient with Mitochondrial Diabetes. Eur J Case Rep Intern Med 2025;12:005197. doi: 10.12890\/2025_005197","DOI":"10.12890\/2025_005197"},{"key":"10.12890\/2026_006063_ref3","doi-asserted-by":"crossref","unstructured":"Kyriakidou A, Hadjivassiliou M, Papapostolou A, Picolos MK. Maternally Inherited Diabetes and Deafness (MIDD) - Atypical Clinical Diabetes Features Leading to the Diagnosis. JCEM Case Rep 2023;1:luad047. doi: 10.1210\/jcemcr\/luad047","DOI":"10.1210\/jcemcr\/luad047"},{"key":"10.12890\/2026_006063_ref4","doi-asserted-by":"crossref","unstructured":"Finsterer J. Mitochondrial diabetes plus phenotypes due to the m.3243A > G variant require correlation with heteroplasmy rates. Clin Case Rep 2024;12:e8862. doi: 10.1002\/ccr3.8862","DOI":"10.1002\/ccr3.8862"},{"key":"10.12890\/2026_006063_ref5","doi-asserted-by":"crossref","unstructured":"Yang M, Xu L, Xu C, Cui Y, Jiang S, Dong J, et al. The Mutations and Clinical Variability in Maternally Inherited Diabetes and Deafness: An Analysis of 161 Patients. Front Endocrinol (Lausanne) 2021;12:728043. doi: 10.3389\/fendo.2021.728043","DOI":"10.3389\/fendo.2021.728043"},{"key":"10.12890\/2026_006063_ref6","doi-asserted-by":"crossref","unstructured":"Murphy R, Turnbull DM, Walker M, Hattersley AT. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 2008;25:383-399. doi: 10.1111\/j.1464-5491.2008.02359.x","DOI":"10.1111\/j.1464-5491.2008.02359.x"},{"key":"10.12890\/2026_006063_ref7","doi-asserted-by":"crossref","unstructured":"Guillausseau PJ, Massin P, Dubois-LaForgue D, Timsit J, Virally M, Gin H, et al. Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 2001;134:721-728. doi: 10.7326\/0003-4819-134-9_part_1-200105010-00008","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00008"},{"key":"10.12890\/2026_006063_ref8","doi-asserted-by":"crossref","unstructured":"Ng N, Sanchez-Lechuga B, McCarrick CJ, Mangan C, Burke M, Ioana JA, et al. Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations. Diabetes Metab 2025;51:101678. doi: 10.1016\/j.diabet.2025.101678","DOI":"10.1016\/j.diabet.2025.101678"},{"key":"10.12890\/2026_006063_ref9","doi-asserted-by":"crossref","unstructured":"Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 2008;21:473-494. doi: 10.1128\/CMR.00001-08","DOI":"10.1128\/CMR.00001-08"},{"key":"10.12890\/2026_006063_ref10","doi-asserted-by":"crossref","unstructured":"Soares MN, Eggelbusch M, Naddaf E, Gerrits KHL, van der Schaaf M, van den Borst B, et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J Cachexia Sarcopenia Muscle 2022;13:11-22. doi: 10.1002\/jcsm.12896","DOI":"10.1002\/jcsm.12896"},{"key":"10.12890\/2026_006063_ref11","doi-asserted-by":"crossref","unstructured":"Kietaibl AT, Fangmeyer-Binder M, G\u00f6nd\u00f6r G, S\u00e4emann M, Fasching P. Acute viral myositis: profound rhabdomyolysis without acute kidney injury. Wien Klin Wochenschr 2021;133:847-850. doi: 10.1007\/s00508-021-01866-3","DOI":"10.1007\/s00508-021-01866-3"},{"key":"10.12890\/2026_006063_ref12","doi-asserted-by":"crossref","unstructured":"Singh AK, Sudhan YG, Ramakrishna R, Durairajan SSK. Viral agents in neuromuscular pathology. Int Rev Neurobiol 2025;180:397-434. doi: 10.1016\/bs.irn.2025.04.007","DOI":"10.1016\/bs.irn.2025.04.007"},{"key":"10.12890\/2026_006063_ref13","unstructured":"Bhai S, Naddaf E, Dimachkie MM. Overview of viral myositis. UpToDate [Internet]. 2024 Sep 24. https:\/\/www.uptodate.com\/contents\/overview-of-viral-myositis"},{"key":"10.12890\/2026_006063_ref14","doi-asserted-by":"crossref","unstructured":"Tanaka T, Takada T, Takagi D, Takeyama N, Kitazawa Y. Acute renal failure due to rhabdomyolysis associated with echovirus 9 infection: a case report and review of literature. Jpn J Med 1989;28:237-242. doi: 10.2169\/internalmedicine1962.28.237","DOI":"10.2169\/internalmedicine1962.28.237"},{"key":"10.12890\/2026_006063_ref15","unstructured":"Fodili F, van Bommel EF. Severe rhabdomyolysis and acute renal failure following recent Coxsackie B virus infection. Neth J Med 2003;61:177-179."},{"key":"10.12890\/2026_006063_ref16","doi-asserted-by":"crossref","unstructured":"McCabe JL, Duckett S, Kaplan P. Epstein-Barr virus infection complicated by acute rhabdomyolysis. Am J Emerg Med 1988;6:453-455. doi: 10.1016\/0735-6757(88)90244-6","DOI":"10.1016\/0735-6757(88)90244-6"},{"key":"10.12890\/2026_006063_ref17","doi-asserted-by":"crossref","unstructured":"Weiss LM, Chen YY. EBER in situ hybridization for Epstein-Barr virus. Methods Mol Biol 2013;999:223-30. doi: 10.1007\/978-1-62703-357-2_16","DOI":"10.1007\/978-1-62703-357-2_16"},{"key":"10.12890\/2026_006063_ref18","doi-asserted-by":"crossref","unstructured":"Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 2005;84:377-385. doi: 10.1097\/01.md.0000188565.48918.41","DOI":"10.1097\/01.md.0000188565.48918.41"},{"key":"10.12890\/2026_006063_ref19","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis 2019;290:140-205. doi: 10.1016\/j.atherosclerosis.2019.08.014","DOI":"10.1016\/j.atherosclerosis.2019.08.014"},{"key":"10.12890\/2026_006063_ref20","doi-asserted-by":"crossref","unstructured":"Hannah-Shmouni F, Al-Sarraf A, Frohlich J, Mezei MM, Sirrs S, Mattman A. Safety of statin therapy in patients with mitochondrial diseases. J Clin Lipidol 2013;7:182. doi: 10.1016\/j.jacl.2012.08.003","DOI":"10.1016\/j.jacl.2012.08.003"}],"container-title":["European Journal of Case Reports in Internal Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/6063\/5066","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/6063\/5067","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/6063\/5067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:38:10Z","timestamp":1770388690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/view\/6063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.12890\/2026_006063","relation":{"has-manifestation":[{"id-type":"other","id":"1-163-6063-g5066","asserted-by":"subject"},{"id-type":"other","id":"1-163-6063-g5067","asserted-by":"subject"}],"is-part-of":[{"id-type":"other","id":"1-163","asserted-by":"subject"}]},"ISSN":["2284-2594"],"issn-type":[{"value":"2284-2594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}